Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Avacta Group (AVCT) Share Price

Price 72.00p on 23-06-2026 at 17:55:08
Change 0.20p 0.28%
Buy 73.00p
Sell 71.00p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Buy 1,633.00 at 72.20p
Day's Volume: 1,327,857
Last Close: 72.20p
Open: 71.00p
ISIN: GB00BYYW9G87
Day's Range 71.00p - 72.20p
52wk Range: 28.50p - 90.50p
Market Capitalisation: £338.29m
VWAP: 71.31362p
Shares in Issue: 468.55m

Sector: Medicine and Biotech

Listed In: FTSE AIM All-Share,

Avacta Group (AVCT) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 1,633 72.20p Suspected BUY Trade
 16:35:09 - 23-Jun-26
Buy* 2,070 72.4464p Ordinary
 16:29:32 - 23-Jun-26
Sell* 15,000 71.8555p Ordinary
 16:28:58 - 23-Jun-26
Buy* 2,500 72.45p Ordinary
 16:27:50 - 23-Jun-26
Buy* 2,755 72.45p Ordinary
 16:25:28 - 23-Jun-26
Buy* 3,799 72.5001p Ordinary
 16:20:30 - 23-Jun-26
Buy* 1,601 72.4744p Ordinary
 16:13:53 - 23-Jun-26
Buy* 196 72.6964p Ordinary
 16:05:57 - 23-Jun-26
Buy* 687 72.6964p Ordinary
 15:52:27 - 23-Jun-26
Buy* 2,257 72.70p Ordinary
 15:51:15 - 23-Jun-26
See more Avacta Group trades

Avacta Group (AVCT) Share Price History

Time period:
to
Date Open High Low Close Volume
22nd Jun 2026 (Mon) 73.00 74.00 72.00 72.00 1,707,421
19th Jun 2026 (Fri) 73.50 73.50 73.00 73.00 975,742
18th Jun 2026 (Thu) 73.50 73.50 73.50 73.50 933,085
17th Jun 2026 (Wed) 73.50 75.00 73.00 73.50 1,654,598
16th Jun 2026 (Tue) 71.00 73.00 70.00 73.00 1,291,815
15th Jun 2026 (Mon) 71.00 71.50 71.00 71.00 761,059
12th Jun 2026 (Fri) 70.00 73.00 68.50 71.00 1,448,605
11th Jun 2026 (Thu) 68.50 70.00 68.00 68.50 1,344,736
10th Jun 2026 (Wed) 70.50 72.00 66.90 68.50 2,673,141
9th Jun 2026 (Tue) 70.50 70.50 70.00 70.50 1,421,968
8th Jun 2026 (Mon) 71.00 71.70 68.50 70.50 2,245,361
5th Jun 2026 (Fri) 70.50 72.50 70.50 71.50 4,669,523
4th Jun 2026 (Thu) 71.00 70.00 70.00 70.00 1,920,750
3rd Jun 2026 (Wed) 74.50 73.80 70.00 70.00 2,489,511
2nd Jun 2026 (Tue) 74.50 75.00 75.00 75.00 1,010,824
1st Jun 2026 (Mon) 79.50 81.00 74.00 74.00 2,062,710
29th May 2026 (Fri) 76.00 79.00 79.00 79.00 1,078,204
28th May 2026 (Thu) 78.00 78.00 74.50 75.50 1,231,944
27th May 2026 (Wed) 78.50 75.00 75.00 75.00 976,429
26th May 2026 (Tue) 78.50 80.50 77.60 77.60 1,144,266
25th May 2026 (Mon) 79.00 79.00 79.00 79.00 0
See more Avacta Group price history

Avacta Group (AVCT) Regulatory News

Date Source Headline
22nd Jun 2026 7:00 am RNS Year-to-date business update ahead of AGM
5th Jun 2026 7:00 am RNS Oversubscribed Strategic Equity Fundraise of £9m
1st Jun 2026 3:00 pm RNS Block Listing - Application to AIM
1st Jun 2026 7:00 am RNS Clinical data on AVA6000 in salivary gland cancers
29th May 2026 7:00 am RNS Posting of Annual Report and Notice of AGM
29th May 2026 7:00 am RNS Board Director Changes
19th May 2026 7:00 am RNS Unaudited Preliminary Full Year 2025 Results
13th May 2026 7:00 am RNS Notice of Preliminary Results and Presentation
13th May 2026 7:00 am RNS Issue of Equity and Total Voting Rights
6th May 2026 7:00 am RNS Pre|CISION® payload release vs approved ADCs
See more Avacta Group regulatory news

Avacta Group (AVCT) Share News

Avacta hails "strong progress" in first half of 2026

22nd Jun 2026 11:58

(Alliance News) - Avacta Group PLC on Monday said it continued its "strong progress" in the first half of 2026. Read More

UK shareholder meetings calendar - next 7 days

15th Jun 2026 13:43

Read More

IN BRIEF: Avacta Group raises GBP9 million for bond repayments

5th Jun 2026 11:15

Avacta Group PLC - London-based clinical-stage biopharmaceutical company - Raises gross proceeds of approximately GBP9 million from institutional investors and existing shareholders, through conditionally placing 12.8 million new shares at 70 pence each. Says one institutional cornerstone investor represents the majority of the funds. Notes that as of late August, the terms of its convertible bond were renegotiated to defer quarterly repayments and interest until October 20, 2027. The bondholder can accelerate the satisfaction of the quarterly repayments from October 1 this year. It will also have the right to accelerate satisfaction of one or both deferred repayments upon publication of Avacta's data readouts from its phase 1b trials of AVA6000 in triple-negative breast cancer or, if earlier, June 30. Avacta says the net placing proceeds will enable it to make the deferred repayments in cash, and make an additional quarterly payment in cash if required. Also notes that Chief Executive Officer Christina Coughlin and Non-Executive Director Mark Goldberg have both invested approximately GBP22,500 by subscribing for 32,142 shares each at the issue price. Read More

EARNINGS AND TRADING: Blencowe updates Orom-Cross net present value

29th May 2026 18:34

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

Avacta Group annual loss widens as cancer treatment trial results loom

19th May 2026 11:07

(Alliance News) - Avacta Group PLC on Tuesday said clinical data from two cancer trials is expected to be released this year as it reported a widened annual pretax loss. Read More

See more Avacta Group news
FTSE 100 Latest
Value10,428.85
Change-9.00

Login to your account

Forgot Password?

Not Registered